Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios (Innolink: 100.918 IP-LS)

• Unité de recherche: INNOSUISSE
• Numéro de projet: 61762.1 IP-LS
• Titre du projet anglais: Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios (Innolink: 100.918 IP-LS)

Description succincte (Allemand)

Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios (Innolink: 100.918 IP-LS)

Description succincte (Anglais)

Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios

Résumé des résultats (Abstract) (Allemand)

Accurate diagnosis is critical in determining the right therapy for carcinoma patients, leading to improved survival rates and quality of life. Nuclidium AG is developing Kalios, a diagnostic agent that enables precise imaging of carcinomas, overcoming all limitations of current imaging modalities.